Annual Net Income
-$94.26 M
-$21.37 M-29.32%
December 31, 2024
Summary
- As of March 14, 2025, ATXS annual net profit is -$94.26 million, with the most recent change of -$21.37 million (-29.32%) on December 31, 2024.
- During the last 3 years, ATXS annual net income has risen by +$100.65 million (+51.64%).
- ATXS annual net income is now -420.26% below its all-time high of -$18.12 million, reached on December 31, 2013.
Performance
ATXS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$25.63 M
-$1.09 M-4.45%
December 1, 2024
Summary
- As of March 14, 2025, ATXS quarterly net profit is -$25.63 million, with the most recent change of -$1.09 million (-4.45%) on December 1, 2024.
- Over the past year, ATXS quarterly net income has increased by +$5.78 million (+18.41%).
- ATXS quarterly net income is now -473.42% below its all-time high of -$4.47 million, reached on March 31, 2014.
Performance
ATXS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$94.26 M
+$5.78 M+5.78%
December 1, 2024
Summary
- As of March 14, 2025, ATXS TTM net profit is -$94.26 million, with the most recent change of +$5.78 million (+5.78%) on December 1, 2024.
- Over the past year, ATXS TTM net income has dropped by -$21.37 million (-29.32%).
- ATXS TTM net income is now -2009.20% below its all-time high of -$4.47 million, reached on March 31, 2014.
Performance
ATXS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ATXS Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.3% | +18.4% | -29.3% |
| 3 y3 years | +51.6% | -44.6% | -72.2% |
| 5 y5 years | -258.5% | -44.6% | -72.2% |
ATXS Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.8% | +51.6% | -170.0% | +18.4% | -134.8% | +51.6% |
| 5 y | 5-year | -258.5% | +51.6% | -287.7% | +84.9% | -258.5% | +52.7% |
| alltime | all time | -420.3% | +51.6% | -473.4% | +84.9% | -2009.2% | +52.7% |
Astria Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$94.26 M(+29.3%) | - | - |
| Dec 2024 | - | -$25.63 M(+4.5%) | -$94.26 M(-5.8%) |
| Sep 2024 | - | -$24.53 M(+1.5%) | -$100.04 M(+7.3%) |
| Jun 2024 | - | -$24.17 M(+21.3%) | -$93.24 M(+14.2%) |
| Mar 2024 | - | -$19.93 M(-36.6%) | -$81.63 M(+12.0%) |
| Dec 2023 | -$72.89 M(+40.6%) | -$31.41 M(+77.2%) | -$72.89 M(+33.1%) |
| Sep 2023 | - | -$17.73 M(+41.1%) | -$54.74 M(+11.7%) |
| Jun 2023 | - | -$12.57 M(+12.3%) | -$49.01 M(+2.8%) |
| Mar 2023 | - | -$11.19 M(-15.6%) | -$47.70 M(-8.0%) |
| Dec 2022 | -$51.83 M(-73.4%) | -$13.26 M(+10.6%) | -$51.83 M(+7.8%) |
| Sep 2022 | - | -$12.00 M(+6.6%) | -$48.06 M(+9.4%) |
| Jun 2022 | - | -$11.25 M(-26.6%) | -$43.94 M(+9.4%) |
| Mar 2022 | - | -$15.32 M(+61.4%) | -$40.15 M(-79.4%) |
| Dec 2021 | -$194.91 M(+422.6%) | -$9.49 M(+20.6%) | -$194.91 M(+0.3%) |
| Sep 2021 | - | -$7.87 M(+5.4%) | -$194.40 M(-1.5%) |
| Jun 2021 | - | -$7.47 M(-95.6%) | -$197.39 M(-1.0%) |
| Mar 2021 | - | -$170.08 M(+1794.5%) | -$199.43 M(+434.7%) |
| Dec 2020 | -$37.30 M(+41.9%) | -$8.98 M(-17.3%) | -$37.30 M(+6.8%) |
| Sep 2020 | - | -$10.86 M(+14.2%) | -$34.93 M(+14.2%) |
| Jun 2020 | - | -$9.51 M(+19.6%) | -$30.58 M(+8.4%) |
| Mar 2020 | - | -$7.95 M(+20.3%) | -$28.21 M(+7.3%) |
| Dec 2019 | -$26.29 M | -$6.61 M(+1.5%) | -$26.29 M(+2.1%) |
| Sep 2019 | - | -$6.51 M(-8.7%) | -$25.74 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$7.13 M(+18.1%) | -$24.91 M(+2.7%) |
| Mar 2019 | - | -$6.04 M(-0.4%) | -$24.26 M(-6.2%) |
| Dec 2018 | -$25.87 M(-5.5%) | -$6.06 M(+6.7%) | -$25.87 M(+2.2%) |
| Sep 2018 | - | -$5.68 M(-12.3%) | -$25.31 M(-5.0%) |
| Jun 2018 | - | -$6.48 M(-15.3%) | -$26.64 M(-1.8%) |
| Mar 2018 | - | -$7.65 M(+39.2%) | -$27.14 M(-0.8%) |
| Dec 2017 | -$27.36 M(-24.1%) | -$5.50 M(-21.7%) | -$27.36 M(-10.7%) |
| Sep 2017 | - | -$7.02 M(+0.6%) | -$30.64 M(-4.4%) |
| Jun 2017 | - | -$6.97 M(-11.5%) | -$32.05 M(-7.2%) |
| Mar 2017 | - | -$7.88 M(-10.3%) | -$34.52 M(-4.3%) |
| Dec 2016 | -$36.06 M(+10.5%) | -$8.78 M(+4.3%) | -$36.06 M(-2.2%) |
| Sep 2016 | - | -$8.42 M(-10.9%) | -$36.89 M(-0.2%) |
| Jun 2016 | - | -$9.45 M(+0.3%) | -$36.95 M(+4.0%) |
| Mar 2016 | - | -$9.42 M(-2.0%) | -$35.55 M(+8.9%) |
| Dec 2015 | -$32.63 M(+49.1%) | -$9.61 M(+13.2%) | -$32.63 M(+12.3%) |
| Sep 2015 | - | -$8.48 M(+5.5%) | -$29.05 M(+9.3%) |
| Jun 2015 | - | -$8.04 M(+23.7%) | -$26.59 M(+11.2%) |
| Mar 2015 | - | -$6.50 M(+7.9%) | -$23.91 M(+9.3%) |
| Dec 2014 | -$21.88 M(+20.8%) | -$6.03 M(+0.0%) | -$21.88 M(+38.0%) |
| Sep 2014 | - | -$6.03 M(+12.3%) | -$15.86 M(+61.3%) |
| Jun 2014 | - | -$5.36 M(+20.0%) | -$9.83 M(+120.0%) |
| Mar 2014 | - | -$4.47 M | -$4.47 M |
| Dec 2013 | -$18.12 M | - | - |
FAQ
- What is Astria Therapeutics annual net profit?
- What is the all time high annual net income for Astria Therapeutics?
- What is Astria Therapeutics annual net income year-on-year change?
- What is Astria Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Astria Therapeutics?
- What is Astria Therapeutics quarterly net income year-on-year change?
- What is Astria Therapeutics TTM net profit?
- What is the all time high TTM net income for Astria Therapeutics?
- What is Astria Therapeutics TTM net income year-on-year change?
What is Astria Therapeutics annual net profit?
The current annual net income of ATXS is -$94.26 M
What is the all time high annual net income for Astria Therapeutics?
Astria Therapeutics all-time high annual net profit is -$18.12 M
What is Astria Therapeutics annual net income year-on-year change?
Over the past year, ATXS annual net profit has changed by -$21.37 M (-29.32%)
What is Astria Therapeutics quarterly net profit?
The current quarterly net income of ATXS is -$25.63 M
What is the all time high quarterly net income for Astria Therapeutics?
Astria Therapeutics all-time high quarterly net profit is -$4.47 M
What is Astria Therapeutics quarterly net income year-on-year change?
Over the past year, ATXS quarterly net profit has changed by +$5.78 M (+18.41%)
What is Astria Therapeutics TTM net profit?
The current TTM net income of ATXS is -$94.26 M
What is the all time high TTM net income for Astria Therapeutics?
Astria Therapeutics all-time high TTM net profit is -$4.47 M
What is Astria Therapeutics TTM net income year-on-year change?
Over the past year, ATXS TTM net profit has changed by -$21.37 M (-29.32%)